{{Rsnum
|rsid=11935103
|Gene=PRAMEF4
|Chromosome=4
|position=186417181
|Orientation=plus
|GMAF=0.2309
|Gene_s=PRAMEF4
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(C;C)
|geno2=(C;T)
|geno3=(T;T)
}}{{ population diversity
| geno1=(C;C)
| geno2=(C;T)
| geno3=(T;T)
| CEU | 48.7 | 46.9 | 4.4
| HCB | 70.8 | 26.3 | 2.9
| JPT | 79.6 | 16.8 | 3.5
| YRI | 65.3 | 30.6 | 4.1
| ASW | 49.1 | 49.1 | 1.8
| CHB | 70.8 | 26.3 | 2.9
| CHD | 57.8 | 35.8 | 6.4
| GIH | 73.3 | 25.7 | 1.0
| LWK | 56.4 | 32.7 | 10.9
| MEX | 56.9 | 34.5 | 8.6
| MKK | 59.0 | 36.5 | 4.5
| TSI | 53.9 | 29.4 | 16.7
| HapMapRevision=28
}}{{PMID Auto GWAS
  |PMID=22760553
  |Trait=Response to citalopram treatment
  |Title=Genome-wide pharmacogenomic study of citalopram-induced side effects in STAR*D.
  |RiskAllele=T
  |Pval=2E-6
  |OR=NR
  |ORtxt=NR
  |OA=1
}}

{{on chip | Affy GenomeWide 6}}
{{on chip | FTDNA}}